SCHEMBL14224799

SCHEMBL14224799

Cc1cc(-c2nc3cccnc3[nH]2)n(C)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.38
NPC1 O15118 3/20 0.38
NPSR1 Q6W5P4 2/20 0.38
RECQL P46063 1/20 0.38
METAP2 P50579 2/20 0.36
METAP1 P53582 2/20 0.36
CBFB Q13951 2/20 0.36
RAB9A P51151 3/20 0.35
PKM P14618 1/20 0.35
ALDH1A1 P00352 5/20 0.35
PRMT5 O14744 1/20 0.35
IGF1R P08069 1/20 0.34
HSD17B10 Q99714 3/20 0.34
MAPT P10636 3/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
HPGD P15428 2/20 0.34
HTT P42858 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
MEN1 O00255 1/20 0.34
ALOX12 P18054 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14224790 0.86 KDM4E (0.37) KDM4ENPC1NPSR1RECQLMETAP2
SCHEMBL14224797 0.78 NPC1 (0.63) KDM4ENPC1NPSR1RECQLRAB9A
SCHEMBL14224800 0.77 KDM4E (0.30) KDM4ENPC1NPSR1RECQLALDH1A1
SCHEMBL25781990 0.77 COMT (0.39) KDM4ENPC1NPSR1RECQLMETAP2
SCHEMBL15633796 0.76 NPC1 (0.46) KDM4ENPC1NPSR1METAP2METAP1
SCHEMBL14224796 0.74 AURKA (0.48) KDM4ENPC1NPSR1RECQLMETAP2
SCHEMBL31440145 0.71 EPHX2 (0.63) KDM4EMAPT
Hydrochloric Acid SCHEMBL30669801 0.70 EPHX2 (0.62) KDM4EMAPT
SCHEMBL279584 0.69 PARP1 (0.44) KDM4ENPC1RAB9AALDH1A1PRMT5
SCHEMBL2668125 0.68 NPC1 (0.56) KDM4ENPC1METAP2RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090816-A1 ANTI-INFECTIVE BIARYL COMPOUNDS GENESOFT PHARMACEUTICALS, INC. (US) 2008-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090816-A1 ANTI-INFECTIVE BIARYL COMPOUNDS QTRT1, Q6ZSR9, QTRT2 KDM4E 3096/4885NPC1 796/4885NPSR1 2494/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.